Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer.
Marec-Berard P, Chastagner P, Kassab-Chahmi D, Casadevall N, Marchal C, Misset JL, Ray-Coquard I. Marec-Berard P, et al. Among authors: casadevall n. Pediatr Blood Cancer. 2009 Jul;53(1):7-12. doi: 10.1002/pbc.21953. Pediatr Blood Cancer. 2009. PMID: 19229970 Review.
[Clinical Practice guidelines for the use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin bêta, darbepoetin) in anaemic patients with cancer: 2007 update (summary report)].
Ray-Coquard I, Kassab-Chahmi D, Casadevall N, Chastagner P, Marchal C, Marec-Bérard P, Misset JL; Standards, Options et Recommandations (SOR); Institut National du Cancer; Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC); Ligue contre le Cancer pour la Vie; Fédération Hospitalière de France; Fédération Nationale de Cancérologiedes Centres Hospitaliers Regionaux et Universitaires (FNCHRU); Fédération Française de Cancérologie; Union Nationale Hospitalière Privée de Cancérologie (UNHPC). Ray-Coquard I, et al. Among authors: casadevall n. Bull Cancer. 2008 Apr;95(4):433-41. doi: 10.1684/bdc.2008.0635. Bull Cancer. 2008. PMID: 18495573 Review. French.
[Standards & options: recommendations for the use of erythropoiesis-stimulating agents (ESA) in anaemic cancer patients undergoing radiotherapy (2007 update)].
Marchal C, Misset JL, Casadevall N, Marec-Bérard P, Chastagner P, Kassab-Chahmi D, Ray-Coquard I; National French Federation of Comprehensive Cancer Centres. Marchal C, et al. Among authors: casadevall n. Cancer Radiother. 2008 Mar;12(2):126-33. doi: 10.1016/j.canrad.2008.01.003. Cancer Radiother. 2008. PMID: 18533282 French.
[Summary version of the Standards, Options and Recommendations for the use of recombinant erythropoietin (epoietin-alpha and beta, darbepoietin-alpha, EPO) in the management of anaemia in oncology - Update 2003].
Spaeth D, Casadevall N, Daouphars M, Marchal C, Marec-Berard P, Fabre N, Haugh M; Standards, Options and Recommendations project. Spaeth D, et al. Among authors: casadevall n. Bull Cancer. 2004 Feb;91(2):179-88. Bull Cancer. 2004. PMID: 15047458 Free article. French.
[Standards, options and recommendations for the use of recombinant erythropoietin (epoietin alpha and beta darbepoietin-alpha, EPO) in the management of anaemia in oncology for patient undergoing radiotherapy-update 2003].
Marchal C, Spaeth D, Casadevall N, Daouphars M, Marec-Berard P, Fabre N, Haugh M; Comité d'organisation des Standards, Options and Recommendations. Marchal C, et al. Among authors: casadevall n. Cancer Radiother. 2004 Jun;8(3):197-206. doi: 10.1016/j.canrad.2004.04.001. Cancer Radiother. 2004. PMID: 15260007 French.
Severe chronic primary neutropenia in adults: report on a series of 108 patients.
Sicre de Fontbrune F, Moignet A, Beaupain B, Suarez F, Galicier L, Socié G, Varet B, Coppo P, Michel M, Pautas C, Oksenhendler E, Lengline E, Terriou L, Moreau P, Chantepie S, Casadevall N, Michot JM, Gardembas M, Michallet M, Croisille L, Audrain M, Bellanné-Chantelot C, Donadieu J, Lamy T; French Severe Chronic Neutropenia Registry. Sicre de Fontbrune F, et al. Among authors: casadevall n. Blood. 2015 Oct 1;126(14):1643-50. doi: 10.1182/blood-2015-03-634493. Epub 2015 Aug 10. Blood. 2015. PMID: 26261239 Free article.
Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial.
Casadevall N, Durieux P, Dubois S, Hemery F, Lepage E, Quarré MC, Damaj G, Giraudier S, Guerci A, Laurent G, Dombret H, Chomienne C, Ribrag V, Stamatoullas A, Marie JP, Vekhoff A, Maloisel F, Navarro R, Dreyfus F, Fenaux P. Casadevall N, et al. Blood. 2004 Jul 15;104(2):321-7. doi: 10.1182/blood-2003-07-2252. Epub 2004 Mar 30. Blood. 2004. PMID: 15054036 Free article. Clinical Trial.
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.
Bennett CL, Cournoyer D, Carson KR, Rossert J, Luminari S, Evens AM, Locatelli F, Belknap SM, McKoy JM, Lyons EA, Kim B, Sharma R, Costello S, Toffelmire EB, Wells GA, Messner HA, Yarnold PR, Trifilio SM, Raisch DW, Kuzel TM, Nissenson A, Lim LC, Tallman MS, Casadevall N. Bennett CL, et al. Among authors: casadevall n. Blood. 2005 Nov 15;106(10):3343-7. doi: 10.1182/blood-2005-02-0508. Epub 2005 Aug 11. Blood. 2005. PMID: 16099877 Free PMC article.
Pure red cell aplasia induced by erythropoiesis-stimulating agents.
Pollock C, Johnson DW, Hörl WH, Rossert J, Casadevall N, Schellekens H, Delage R, De Francisco A, Macdougall I, Thorpe R, Toffelmire E. Pollock C, et al. Among authors: casadevall n. Clin J Am Soc Nephrol. 2008 Jan;3(1):193-9. doi: 10.2215/CJN.02440607. Clin J Am Soc Nephrol. 2008. PMID: 18178785 Review.
210 results